Related Experiment Videos

Clinical issues surrounding once-daily aminoglycoside dosing in children

Chad A Knoderer1, Julie A Everett, William F Buss

  • 1Department of Pharmacy Services, James Whitcomb Riley Hospital for Children, Indianapolis, Indiana 46202, USA. cknoderer@clarian.org

Pharmacotherapy
|January 14, 2003
PubMed

Insights

Once-daily aminoglycoside antibiotic dosing shows promise in children, matching adult efficacy with potentially lower toxicity. Further pediatric research is needed to overcome barriers to adopting this simpler dosing strategy.

Area of Science:

  • Pediatric Infectious Diseases
  • Pharmacokinetics
  • Antibiotic Stewardship

Background:

  • Aminoglycoside antibiotics are crucial for treating pediatric infections.
  • Current pediatric dosing (every 8-12 hours) differs from adult once-daily regimens.
  • Adult studies suggest once-daily dosing is effective and safe.

Purpose of the Study:

  • To evaluate the feasibility and potential benefits of once-daily aminoglycoside dosing in children.
  • To address the lack of pediatric data hindering adoption of once-daily regimens.
  • To explore reasons for the slow uptake of once-daily aminoglycoside dosing in pediatric hospitals.

Main Methods:

  • Review of existing adult and pediatric studies on aminoglycoside dosing.
  • Analysis of pharmacokinetic data in children, including clearance rates.
  • Assessment of safety and efficacy data for once-daily versus traditional dosing.

Main Results:

  • Adult studies demonstrate equivalent efficacy and reduced toxicity with once-daily aminoglycoside regimens.
  • Pediatric populations exhibit rapid aminoglycoside clearance, complicating once-daily dosing.
  • Limited pediatric clinical and efficacy data, alongside safety concerns, impede widespread adoption.

Conclusions:

  • Once-daily aminoglycoside dosing presents a potentially simpler and safer alternative for pediatric patients.
  • Further pediatric-specific research is essential to establish safety, efficacy, and optimal dosing intervals.
  • Overcoming barriers like rapid clearance and limited data is key to implementing once-daily aminoglycoside therapy in children.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...